NCT04348942View on ClinicalTrials.gov

A COVID-19 Symptom, Exposure and Immune Response Registry

CompletedOBSERVATIONAL

Enrollment

804

Participants

Timeline

Start Date

May 29, 2020

Primary Completion Date

March 21, 2021

Study Completion Date

March 21, 2021

Conditions

COVID-19

Trial Locations (1)

328017

ObvioHealth, Orlando

All Listed Sponsors

lead

ObvioHealth

INDUSTRY

NCT04348942 - A COVID-19 Symptom, Exposure and Immune Response Registry | Biotech Hunter | Biotech Hunter